Back to YC Companies
Origin
Winter 2026
Active
AI and Data for Cancer Therapeutics
8 people View on YC
Origin at a glance
- Y Combinator batch
- Winter 2026
- Status
- Active
- Industry
- Healthcare
- Team size
- 8 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Origin
We produce patient-derived cancer datasets for licensing to pharmaceutical and AI companies. Our data comprises matched spatial transcriptomics, H&E and clinical labels. We operate our own laboratory, where samples are processed. Samples are sourced from leading biobank / hospital networks. As R&D workflows increasingly rely on frontier AI systems, we believe there is critical need for real world datapoints so that findings translate in the clinic.
Tags:
AI-powered Drug Discovery
Biotech
AI